Colitis, Ulcerative Clinical Trials in Chicago, Illinois

3 studies are recruiting for colitis, ulcerative in Chicago, Illinois right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

    Study IIBD is a master protocol that will support a collection of individual sub studies that share key design components. Participants will be assigned to the appropriate study prior to randomization to a treatment group. The studies aim to evaluate the efficacy and safety of new treatments in adu…

    Stage
    Phase 2
    Ages
    18 to 80
    Site
    Rush University Medical Center, Chicago, Illinois
    Locations
    70 in total
    Run by
    Eli Lilly and Company

    See if you can join NCT07483073 on ClinicalTrials.gov

  2. A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

    This is a Phase 2, multicenter, proof-of-concept platform study in adult participants with moderately to severely active ulcerative colitis (UC). The primary goal of the study is to assess the efficacy and safety of multiple interventions following intravenous (IV) induction and subcutaneous (SC) m…

    Stage
    Phase 2
    Ages
    18 to 75
    Site
    Site 038, Chicago, Illinois
    Locations
    267 in total
    Run by
    Spyre Therapeutics, Inc.

    See if you can join NCT07012395 on ClinicalTrials.gov

  3. An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis

    The purpose of this observational study is to learn about the effects of etrasimod as a treatment for adult patients with moderate to severe ulcerative colitis. Patients will be treated according to standard of care and will only be included in the study if etrasimod is the best treatment of choice…

    Stage
    Not phased
    Ages
    18 to 64
    Site
    Feinberg School of Medicine Northwestern University, Chicago, Illinois
    Locations
    28 in total
    Run by
    Pfizer

    See if you can join NCT06398626 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.